HAISHUN(SZ:300501)2022-12-06 05:08Group 1: Business Expansion and Strategy - The company has established a subsidiary in Germany to expand overseas business and introduce advanced foreign technologies and products [3] - The company aims to become a one-stop supplier of pharmaceutical consumables, with strategic acquisitions such as controlling Zhejiang Duoling and fully acquiring Suzhou Qingyi to achieve this goal [3][4] - The company is actively responding to the "Belt and Road" initiative by promoting its products to countries along the route [7] Group 2: Production Capacity and Projects - The new production base in Suzhou is nearing completion with an annual capacity of 12,000 tons, combining the original 6,000 tons and an additional 6,000 tons from fundraising projects [3] - There are currently no new production base construction plans, as the focus is on completing existing fundraising projects [6][8] - The company expects to achieve over 50% growth in performance after the completion of fundraising projects, despite a temporary slowdown due to capacity constraints [5] Group 3: Financial Performance and Market Trends - The company has a core product gross margin that is relatively high, with a business model based on sales-driven production [7] - The overall market for children's protective pharmaceutical packaging solutions is not showing significant growth trends [4] - The cold-pressed aluminum packaging material is gaining popularity, with good market promotion conditions [4][6] Group 4: Investor Relations and Market Management - The company is actively managing its market value and will take measures to stabilize stock prices if they decline [4] - The company has a detailed policy to address cost pressures from rising raw material prices [6] - The company plans to utilize capital markets for various operations to achieve its goal of becoming a leader in the industry [6][8]